Table 3.
n | ADAMTS13 | Mean ± SD | Median | 25th percentile | 75th percentile | Minimum | Maximum | |
Young controls | 41 | Activity | 823.7 ± 154.6* | 823.5 | 696.3 | 949.8 | 511.4 | 1,140.0 |
Concentration | 770.6 ± 146.0 | 786.0 | 640.2 | 881.2 | 514.0 | 1,026.0 | ||
Aged controls | 50 | Activity | 709.4 ± 166.8** | 694.3 | 600.1 | 779.4 | 414.0 | 1,415.0 |
Concentration | 681.3 ± 127.7 | 668.1 | 601.9 | 763.9 | 462.2 | 1,124.0 | ||
CAD patients | 70 | Activity | 636.3 ± 146.0 | 621.8 | 549.3 | 696.8 | 343.2 | 1,010.0 |
Concentration | 586.7 ± 146.6 | 561.0 | 480.5 | 681.1 | 308.5 | 887.9 |
All values are expressed in nanograms per milliliter.
P < 0.001 vs. ADAMTS13 activity in CAD patients.
P < 0.05 vs. ADAMTS13 activity in CAD patients.